Two Onc Docs

This week’s episode will be focusing on acquired causes of underproduction anemias. We will go over the important details on iron deficiency, vitamin B12 and folate deficiencies as well as anemia of chronic disease, anemia of pregnancy, and a few other rarer causes of underproduction anemias. This topic will come up time and time again during consults, clinic and of course on test day.

This week’s episode will be focusing on occult cancers, or cancers of unknown primary (or CUP). We will go over the important details on the work-up, diagnostic markers, molecular testing, as well as treatment options. 

This week’s episode will be focusing on Mantle Cell Lymphoma. We will go over the important details on the presentation, diagnosis and treatment.

This week’s episode will be focusing on a rare tumor: Adrenocortical Carcinoma. We will go over the important details on the presentation, diagnosis and treatment.

Happy 2024 and welcome to our THIRD season of Two Onc Docs! This week’s episode will be focusing on Hairy Cell Leukemia, we will cover important details on the symptoms, diagnosis and treatment of hairy cell leukemia. 

Today’s episode we will cover 2023 updates for metastatic bladder cancer. We will discuss staging, treatment options (with EV-302 groundbreaking updates), and variant histologies. We are so excited to have Dr. Tom Powles and Dr. Brian Rini from the urologic oncology podcast Uromigos sharing their expertise on today's episode as well!

Today’s episode we will cover 2023 updates for localized bladder cancer. We will discuss the presentation, diagnostic work-up, staging, and treatment options. We are so excited to have Dr. Tom Powles and Dr. Brian Rini from the urologic oncology podcast Uromigos sharing their expertise on today's episode as well!

This week’s episode will be focusing on one of the Non-Hodgkin Lymphomas: Follicular Lymphoma. We will go over the important details on diagnostic criteria, indications for treatment and treatment options.

This week we are updating our Metastatic Non-Small Cell Lung Cancer episode. We will cover important details on the quickly growing and changing systemic therapy options including traditional chemotherapy, immunotherapy and targeted agents.

This week’s episode is our 2023 update of the treatment landscape of early stage and locally advanced Non-Small Cell Lung Cancer (NSCLC). We will cover important details on pathology, staging, local and systemic therapy options, and special scenarios. 

This week’s episode will be focusing on some of the most testable thrombophilia syndromes including Antiphospholipid Syndrome, Antithrombin III deficiency, Protein C and S deficiency, Factor V Leiden, and Prothrombin mutations. We will go over important details on the presentation, diagnostic testing, and treatment.

This week’s episode is a 2023 update focusing on metastatic breast cancer. We will cover important details on systemic therapy related to metastatic breast cancer & key toxicities.

This week’s episode  is part 2 of 2023 updates focusing on treatment options for localized breast cancer. We will discuss important details on radiation, as well as therapies based on ER/PR/her2 receptor status.

We are continuing our 2023 updates, this week’s episode will be an intro to breast cancer. Today’s will include high yield tips on screening, prevention, ductal carcinoma in situ DCIS, lobular carcinoma in situ LCIS, as well as introduce invasive localized disease.

This week’s episode is a quick one, focusing on heparin induced thrombocytopenia (HIT). We will go over the the pathophysiology, diagnosis and treatment of HIT.

This week’s episode will be focusing on Hematopoietic Stem Cell Transplant. We will go over the important details on the different types of SCT, where stem cells can be collected from, conditioning regimens as well as complications to be aware of for boards. This is a robust field so remember by no means is this short episode all of SCT but rather a quick overview for highest yield information for...

Today’s episode is covering the treatment options for M0 castrate resistant prostate cancer as well as metastatic castrate-sensitive and castrate-resistant prostate cancer, including some 2023 updates.

We are diving into 2023 updates on our 2 part episode on localized and metastatic cancer. This episode will cover localized prostate cancer, as well as introduce biochemical recurrence.

Today’s episode is a 2023 update on the management of metastatic colon cancer. This will include an overview of molecular studies, treatment options and their toxicities.

Today’s episode is a 2023 update on what you need to know regarding early stage colon cancer. We will go over all the important details on the diagnosis, presentation, diagnostic work-up, staging, treatment, and surveillance.

This week’s episode will be focusing on hemolytic anemia. We will primarily focus on acquired forms of hemolytic anemia which include warm autoimmune hemolytic anemia (WAIHA), cold agglutinin disease (CAD), paroxysmal cold hemoglobinuria (PCH), and briefly cover a few other key differentials.

This week’s episode will be focusing on inherited platelet disorders. We will go over the important details on the roles of platelets, the  diagnosis of inherited platelet disorders through aggregation studies, as well as the treatment of these disorders.

This week’s episode will be focusing on one more of the myeloproliferative neoplasms, Primary Myelofibrosis (PMF). We will go over important details on the diagnosis, risk stratification  and treatment options.

This week’s episode will be focusing on Esophageal and Gastrosophageal Junction (GEJ) Cancers. We will go over high yield details on the risk factors, diagnosis, and treatment for both localized and metastatic esophageal cancer.

This week’s episode will be focusing on another one of the myeloproliferative neoplasms (MPN): Polycythemia Vera (PV). We will go over the important details on the diagnosis, risk stratification, and treatment.